Results 141 to 150 of about 13,230,245 (270)

Single‐cell DNA methylation profiling: Technologies, computation, and applications in precision oncology

Molecular Oncology, EarlyView.
Single‐cell DNA methylation (scDNAme) profiling maps epimutational clonal evolution, revealing mechanisms of malignancy and therapeutic resistance across diverse cancer types. By providing a high‐resolution landscape of intratumoral heterogeneity, these technologies empower precise patient stratification, guide the development of enhanced ...
Ik Soo Kim
wiley   +1 more source

The Use of Cell-free Protein Synthesis to Push the Boundaries of Synthetic Biology. [PDF]

Biotechnol Bioprocess Eng, 2023
Kim KJ, Lee SJ, Kim DM.
europepmc   +1 more source

Targeting transcription factors associated with hemoglobinopathies: Lessons from successful interventions and implications for cancer

Molecular Oncology, EarlyView.
This review summarizes the transcription factors, repressive chromatin‐modifying complexes, and epigenetic mechanisms that control fetal hemoglobin repression. Notably, many regulators of γ‐globin silencing also function in transcriptional and epigenetic networks that drive cancer, highlighting opportunities to translate advances in hemoglobinopathy ...
Meigen Yu, Puspa Das, Xing Zhang, Xiaodong Cheng   +3 more
wiley   +1 more source

Cell-Free Protein Synthesis in Porous Parylene Scaffolds. [PDF]

Small Methods
Lee G, Lee SJ, Park MJ, Chen HY, Lahann J, Kim DM, Lee KJ.   +6 more
europepmc   +1 more source

Cell-Free Protein Synthesis of Particulate Methane Monooxygenase into Nanodiscs. [PDF]

ACS Synth Biol, 2022
Koo CW, Hershewe JM, Jewett MC, Rosenzweig AC.   +3 more
europepmc   +1 more source

CEACAM1 participation in breast cancer progression

Molecular Oncology, EarlyView.
In invasive breast cancer (BC), CEACAM1 shifts from an apical to a uniform membranous/cytoplasmic pattern, or is lost, as tumors dedifferentiate, inversely tracking the Ki‐67 proliferative index. In MCF‐7 cells, only CEACAM1‐4L suppresses proliferation, repressing cell cycle and growth factor genes.
Mykola Lyndin, Irina Kube‐Golovin, Anatolii Romaniuk, Gunther Wennemuth   +3 more
wiley   +1 more source

A simplified and highly efficient cell-free protein synthesis system for prokaryotes. [PDF]

Elife
Lang X, Zhang C, Lin J, Zhang Z, Li W.
europepmc   +1 more source

Regulated N-Terminal Modification of Proteins Synthesized Using a Reconstituted Cell-Free Protein Synthesis System. [PDF]

ACS Synth Biol, 2023
Matsumoto R, Niwa T, Shimane Y, Kuruma Y, Taguchi H, Kanamori T.   +5 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Microbial cell-free protein synthesis and its progression toward industrial use. [PDF]

Microbiology (Reading)
Aw R.
europepmc   +1 more source